Surgery should still remain the prior option for treating operable early-stage non-small-cell lung cancer

Eur J Cardiothorac Surg. 2022 Jun 15;62(1):ezac327. doi: 10.1093/ejcts/ezac327.

Authors

Lei Peng^{1

2}, Han-Yu Deng¹, Yun Wang²

Affiliations

¹ Lung Cancer Center, West China Hospital of Sichuan University, Chengdu, China.
² Department of Thoracic Surgery, West China Hospital of Sichuan University, Chengdu, China.

PMID: 35640114
DOI: 10.1093/ejcts/ezac327

No abstract available

Keywords: Early-stage NSCLC; SBRT; Surgery.

Publication types

Letter
Comment

MeSH terms

Carcinoma, Non-Small-Cell Lung* / pathology
Carcinoma, Non-Small-Cell Lung* / surgery
Humans
Lung Neoplasms* / pathology
Lung Neoplasms* / surgery
Neoplasm Staging
Pneumonectomy
Radiosurgery*